HIV-related issues and concerns for imprisoned persons throughout the world

Current Opinion in Psychiatry

Volumn 18, Issue 5, 2005, Pages 530-535

  Seal, David Wyatt ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

AIDS; Corrections; HIV; Prison; Risk behaviors

Indexed keywords

ANTIRETROVIRUS AGENT;

COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DRUG USE; HEALTH CARE DELIVERY; HEALTH SERVICE; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MENTAL DISEASE; PATIENT COMPLIANCE; PRISONER; REVIEW; RISK REDUCTION; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; VIRUS TRANSMISSION;

EID: 23944504356     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yco.0000179492.08064.de     Document Type: Review

References (54)

1. Walmsley R. World prison population list. 5th ed. Research, Development, and Statistics Directorate, Communication Development Unit, London, http:// www.csdp.org/research/r234.pdf. [Accessed 31 March 2005]
2. Canadian HIV/AIDS Information Centre. HIV/AIDS and hepatitis C in prisons: the facts. 3rd ed. http://www.aidslaw.ca/Maincontent/issues/prisons. htm. [Accessed 31 March 2005]
3. Macher AM, Goosby EP. The incarcerated: a report from the 12th World AIDS Conference, http://www.hopkins-aids.edu/geneva/hilites_macer.html. [Accessed 31 March 2005]
4. Zavala D. Tuberculosis and HIV in prisons. Pan American Health Organization, World Health Organization. http://www.pabo.org/English/AD/DPC/CD/ tb-prisons-zavala.ppt. [Accessed 31 March 2005]
5. Bryan A, Aiken LS, West SG. HIV/STD risk among incarcerated adolescents: optimism about the future and self-esteem as predictors of condom use self-efficacy. J Appl Soc Psychol 2004; 34:912-936. A psychosocial model of condom-use intentions was tested with 150 predo-minantly male adolescents, ages 13-17, who were incarcerated.
6. Bryan A, Rocheleau CA, Robbins RN, Hutchinson KE. Condom use among high-risk adolescents: testing the influence of alcohol use on the relationship of cognitive correlates of behavior. Health Psychol 2005; 24:133-142. This study explored the distal effects of alcohol use on condom use among 300 predominantly male criminally involved adolescents, ages 12-18.
7. Crosby R, Salazar LF, DiClemente RJ, et al. Health risk factors among detained adolescent females. Am J Prev Med 2004; 27:404-410. Assessed sexual and substance-use behavior and correlates among 197 adolescent females, ages 14-18, who were incarcerated in a detention facility.
8. Lederman CS, Dakof GA, Larrea MA, Li H. Characteristics of adolescent females in juvenile detention. Int J Law Psychiatry 2004; 27:321-337. Assessed sexual and substance-use behavior and correlates among 493 predominantly African-American or Hispanic adolescent females, ages 10-17, entering a juvenile detention center.
9. Braithwaite R, Stephens T. Use of protective barriers and unprotected sex among adult male prison inmates prior to incarceration. Int J STD AIDS 2005; 16:224-226. Described predictors of protective barrier use and unprotected sexual intercourse among adult men who were incarcerated.
10. Braithwaite R, Stephens T, Conerly RC, et al. The relationship among marijuana use, prior incarceration, and inmates' self-reported HIV/AIDS risk behaviors. Addictive Behav 2004; 29:995-999. Explored the relationship between marijuana use and prior incarceration with the HIV/AIDS risk behavior of 208 adult men incarcerated in a state prison.
11. Green BL, Miranda J, Daroowalla A, Siddique J. Trauma exposure, mental health functioning, and program needs of women in jail. Crime Delinquency 2005; 51:133-151. One-hundred adult women who were incarcerated in a county correctional facility were interviewed to assess trauma exposure, psychopathology, sexual risk behavior, substance use, parenting skills, and service-need perceptions.
12. Mullings JL, Marquart JW, Carr T, Hartley DJ. Knowledge is not always power: HIV risk behavior and the perception of risk among women prisoners. J Correctional Health Care 2004; 11:59-78. Assessed the relationship between drug-treatment history, HIV risk perceptions, and HIV risk behavior among 1198 incarcerated adult women.
13. Rosengard C, Clarke JG, DaSilva K, et al. Correlates of partner-specific condom use intentions among 221 incarcerated adult women in Rhode Island. Perspect Sexual Reprod Health 2005; 37:32-38. Correlates of condom-use intentions with main and casual sexual partners following release from prison were examined among 221 incarcerated adult women.
14. Stephens T, Braithwaite R, Tiggs C. Correlates of inmates' self-reported HIV/ AIDS risk behaviors, prior incarceration, and marijuana use. Am J Drug Alcohol Abuse 2004; 30:287-298. Assessed the association between prior incarceration, marijuana use, and HIV/ AIDS risk behavior among 230 adult men within 60-90 days of their release from prison.
15. Swartz JA, Lurigio AJ, Weiner DA. Correlates of HIV-risk behaviors among prison inmates: implications for tailored AIDS prevention programming. Prison J 2004; 84:486-504. Assessed sexual and drug-use practices, HIV risk-reduction knowledge, perceived HIV status, and perceived ability to avoid HIV infection among a probability sample of 526 adult men and 104 adult women incarcerated in a state prison.
16. Belenko S, Langley S, Crimmins S, Chaple M. HIV risk behaviors, knowledge, and prevention education among offenders under community supervision: a hidden risk group. AIDS Educ Prev 2004; 16:367-385. Described HIV risk behavior, knowledge, and prevention education experiences among 200 adult probationers and parolees in New York City. This study is noteworthy in that it is one of the few published studies that focused on risk behavior among people under correctional jurisdiction in the community.
17. Fotiadou M, Livaditis M, Manou I, et al. Self-reported substance misuse in Greek male prisoners. Eur Addiction Res 2004; 10:56-60. Explored levels and severity of self-reported alcohol and drug misuse and associated physical and mental health problems in 80 randomly selected incarcerated adult men in northern Greece.
18. Miranda AE, Mercon-de-Vargas PR, Viana MC. Sexual and reproductive health of female inmates in Brazil [in Portuguese]. Rev de Saude Publica 2004; 38:255-260. Examined the sexual health behavior of 121 incarcerated adult women in Espirito Santo, Brazil.
19. Dolan K, Lowe D, Shearer J. Evaluation of the condom distribution program in New South Wales prisons Australia. J Law Med Ethics 2004; 32:124-128. Evaluated the first 12 months of condom distribution from free vending machines in New South Wales prisons. Data are presented about the extent to which men obtained condoms and used them when having sex while incarcerated. No major condom distribution-related consequences were reported by incarcerated men or correctional personnel. Prevention implications are presented.
20. Seal DW, Belcher L, Morrow K, et al. A qualitative study of substance use and sexual behavior among 18 to 29-year-old-men while incarcerated in the United States. Health Edu Behav 2004; 31:775-789. Described men's perceptions of and experience with substance use and sexual behavior during incarceration among 80 men, aged 18-29, in four states in the USA. The prevalence and context of in-prison substance use and sexual behavior are described. Prevention implications are discussed.
21. Long J, Allwright A, Begley C. Prisoners' view of injecting drug use and harm reduction in Irish prisons, Int J Drug Policy 2004; 15:139-149. Qualitative methods were used to examine views of drug-injecting practices and harm-reduction interventions among 31 adult men incarcerated in Dublin prisons.
22. Saiz de la Hoya P, Bedia M, Murcia J, et al. Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison [in Spanish]. Enferm Infecc y Microbiol Clin 2005; 23:53-57. Assessed HIV and hepatitis C virus prevalence and correlates among 800 people incarcerated in a Spanish prison.
23. Garcia-Guerrero J, Herrero A, Bedia M, et al. Primary HIV drug resistance in a prison population. REPROCOVA-2 Study [in Spanish]. Enferm Infecc y Microbiol Clin 2004; 22:29-31. Examined HIV drug-resistant mutations among 90 chronically infected treatment-naive people incarcerated in a Spanish prison. Seven samples showed evidence of HIV drug-resistant mutation. The authors concluded that resistance testing is not required before prescribing initial antiretroviral therapy in patients.
24. Strazza L, Azevedo RS, Carvalho HB, Massad E. The vulnerability of Brazilian female prisoners to HIV infection. Brazil J Med Biol Res 2004; 37:771-776. Examined prevalence and correlates of HIV, syphilis, and hepatitis C virus infection among 290 women incarcerated in Sao Paulo State Penitentiary in Brazil.
25. Sabbatani S, Giuliani R, Fulgaro C, et al. HIVAb, HCVAb and HbsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests [in Italian]. Epidemiol Prevenzione 2004; 28:163-168. Evaluated HIV, hepatitis C virus, and hepatitis B virus prevalence and correlates among 433 Italians and foreigners incarcerated in a prison in Bologna.
26. Baillargeon J, Black SA, Leach CT, et al. The infectious disease profile of Texas prison inmates. Prevent Med 2004; 38:607-612. Examined the health records of 336 668 people incarcerated in the Texas criminal justice system during 1999-2001 to document the prevalence and correlates of major infectious diseases. This study is noteworthy for its comprehensive scope, the duration of study, and the large sample size.
27. Baillargeon J, Pollock BH, Leach CT, Gao SJ. The association of neoplasms and HIV infection in the correctional setting. Int J STD AIDS 2004; 15:348-351. This is the sister study to [26]; it examined the health records of 336 668 people incarcerated in the Texas criminal justice system during 1999-2001 to examine the prevalence and correlates of cancer among people with HIV infection. Again, it is noteworthy for its comprehensive scope, the duration of study, and the large sample size.
28. Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Pub Health 2004; 94:1218-1223. Assessed prevalence of HIV, hepatitis B virus, and hepatitis C virus among 4269 men entering the Rhode Island Adult Correctional Institute and among 446 inmates incarcerated continuously for at least 12 months.
29. Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health 2004; 81:25-37. Assessed the prevalence and correlates of hepatitis C virus and the co-morbidity of hepatitis B virus and HIV infection among entrants (predominantly male and African-American) into the Maryland Division of Correction (n = 1081) and the Baltimore City Detention Center (n = 2833).
30. De Ravello L, Brantley MD, Lamarre M, et al. Sexually transmitted infections and other health conditions of women entering prison in Georgia, 1998-1999. Sex Trans Dis 2005; 32:247-251. Examined the prison records of 3636 adult women to determine pregnancy and infectious disease prevalence identified by their admission screening tests.
31. Rahbar AR, Rooholamini S, Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashad Iran. Int J Drug Policy 2005; 15:151-155. Estimated the prevalence and correlates of HIV infection and other blood-borne infections among incarcerated and non-incarcerated injection drug users in Mashad, Iran.
32. De Oliveira HB, Cardoso JC. Tuberculosis among city jail inmates in Campinas, Sao Paulo, Brazil [in Brazilian]. Rev Panam Salud Publica 2004; 15:194-199. Assessed the incidence of tuberculosis among 4293 people incarcerated in a municipal prison system in Sao Paulo, Brazil, from 1993 to 2000, and determined the percent of tuberculosis-positive individuals who had obtained an HIV test, were infected with HIV, or had AIDS. Comparisons were made to HIV/AIDS incidence among tuberculosis patients in the general community.
33. Resch S, Altice FL, Paltiel AD. Cost-effectiveness of HIV screening for incarcerated pregnant women. J Acquir Immune Defic Syndr 2005; 38:163-173. Reported results of a cost-effectiveness analysis of alternative HIV screening strategies to reduce perinatal HIV transmission among incarcerated women in the United States: mandatory newborn screening, routine prenatal screening, and voluntary prenatal screening. Both cost- and prevention-effectiveness of various alternatives are discussed.
34. Zack B, Grinstead O, Faigeles B. Health promotion intervention for prison inmates with HIV. In: Bowser BP, Mishra SI, et al., editors. Preventing AIDS: community-science collaborations. New York: Haworth Press; 2004. pp. 97-114. Described and reported evaluation outcomes from a prerelease intervention with 123 HIV-infected people in a state prison. Intervention participants were more likely than comparison participants to have utilized community resources following release from prison and less likely to have engaged in HIV-related sexual or injection-drug-use risk behavior. This study is noteworthy in that it is one of only two published articles in the past 15 months to present outcome data for HIV prevention intervention.
35. Kelly PJ, Martinez E, Medrano M. Gender-specific health education in the juvenile justice system. J Correctional Health Care 2004; 11:45-58. Described a pilot intervention study conducted with a sample of predominantly Hispanic adolescent females incarcerated in a juvenile detention center. Girls Talk-2 was a peer-led, small-group curriculum aimed at impacting knowledge and attitudes about sexual risk behaviors and violence prevention. This study is noteworthy in that it is one of only two published articles in the past 15 months to present outcome data for HIV prevention intervention.
36. Rosen DL, Golin CE, Schoenbach VJ, et al. Availability of and access to medical services among HIV-infected inmates incarcerated in North Carolina county jails. J Health Care Poor Underserved 2004; 15:413-425. Assessed HIV-related services in county jails in North Carolina and staff perceptions of HIV-infected individuals and their care during and after incarceration. Study highlighted the paucity of confidential health-care services for HIV-positive people who are incarcerated, and the lack of transitional health-care services upon release.
37. Nicholson-Crotty J, Nicholson-Crotty S. Social construction and policy implementation: Inmate health as a public health issue. Soc Sci Q 2004; 85:240-256. Tested a multi-stage approach for assessing the impact of social construction on the implementation of public programs designed to benefit negatively constructed groups. Analysis of 50 state correctional systems revealed that the states with the most negative construction of criminals and potential criminals spent dramatically less on inmate health relative to other states.
38. Flanagan NA. Transitional health care for offenders being released from United States Prisons. Can J Nurs Res 2004; 36:38-58. Evaluated transitional health-care services in 33 prison systems in the USA for people with AIDS, tuberculosis, hepatitis, mental illness, and/or substance-abuse needs. Although most surveyed prison systems provided some type of transitional health-care services or referrals, the extent and quality of care varied widely across prison systems and few offered adequate provision for continuity of medication-treatment regimes initiated in prison.
39. Springer SA, Pesanti E, Hodges J, et al. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis 2004; 38:1754-1760. Examined responses to HAART in correctional settings and their sustained benefit after prison release through a retrospective cohort study of longitudinally linked demographic, pharmacy, and laboratory data from a Connecticut prison system for the years 1997-2002. Among 1099 people meeting study inclusion criteria, the mean CD4 lymphocyte count increased and the mean RNA level decreased during incarceration, a positive health change that was not sustained among people released to the community.
40. Stephenson BL, Wohl DA, Golin CE, et al. Effect of release from prison and reincarceration on the viral loads of HIV-infected individuals. Public Health Rep 2005; 120:84-88. The effect of release from a US prison and subsequent reincarceration on the viral loads of 15 HIV-infected people on HAART was compared to a matched cohort of 30 HIV-infected prisoners on HAART who remained continuously incarcerated.
41. Palepu A, Tyndall MW, Chan K, et al. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antiviral Ther 2004; 9:713-719. Examined the impact of incarceration within 12 months of initiating HAART on nonadherence and HIV-1 RNA suppression among people who were HIV-infected, naive to HAART, and prescribed treatment. Study was conducted in Canada.
42. Herta KD, Sturzenegger M, Berkhoff M. Human immunodeficiency virus-associated tuberculous meningoencephalitis causing abnormal behavior in a prisoner [in German]. Nervenarzt 2005; 76:68-81. Reported on a case study of a 20-year-old African HIV-1-positive man who was diagnosed with delirium caused by AIDS-defining tuberculous meningoencephalitis.
43. Sankaranarayanan N, Agrawal R, Guinipero L, et al. Self-performed peritoneal dialysis in prisoners. Adv Periton Dialysis 2004; 20:98-100. Reported on a retrospective chart review of peritoneal dialysis patients in a US correctional system to identify causes of renal failure.
44. Remollino C, Brown HW, Adelson-Mitty J, et al. Lower genital tract infections among HIV-seropositive and HIV-seronegative incarcerated women: a mandate for screening and treatment in prisons. J Correctional Health Care 2004; 10:527-542. Examined the prevalence of lower genital tract infection and risk factors among 20 HIV-positive and 40 HIV-negative women incarcerated in a US state prison.
45. Ruddy M, Balabanova Y, Graham C, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region Russia. Thorax 2005; 60:130-135. A cross-sectional survey with 600 patients (including 291 prisoners) with tuberculosis was conducted in Samara Oblast, Russia, to examine correlates of drug resistance, including HIV co-infection.
46. Comfort M, Grinstead O, McCartney K, et al. "You can't do nothing in this damn place": sex and intimacy among couples with an incarcerated male partner. J Sex Res 2005; 42:3-12. Investigated the development and maintenance of heterosexual couples' intimacy during male-partner incarceration through in-depth interviews with the 20 female partners of incarcerated men and 13 correctional officers who interact with prison visitors.
47. Dillon B, Allwright S. Prison officers' concerns about blood borne viral infections. Howard J Criminal Justice 2005; 44:29-40. Reported on the knowledge and risk perceptions related to HIV and other blood-borne infections among prison officers in Dublin, Ireland.
48. Salina DD, Hill JL, Solarz AL, et al. Feminist perspectives: empowerment behind bars. In: Jason LA, Keys CB, Suarez-Balcazar Y, et al., editors. Participatory community research: theories and methods in action. APA Decade of Behavior volumes. Washington DC: APA; 2004. pp. 159-175. Described the background and developmental process of the Women's Health, Empowerment, and STD/HIV Prevention Project. This project was developed within a feminist framework to provide a comprehensive STD-/HIV-prevention and empowerment program to incarcerated women in a large urban jail. The challenges of conducting this participatory action research plan are discussed.
49. Devilly GJ, Sorbello L, Eccleston L, Ward T. Prison-based peer-education schemes. Aggression Violent Behav 2005; 10:219-240. Explored the theoretical underpinnings of peer-education programs, reviews research on correctional peer-education programs, discusses the difficulties of such programs, and makes recommendations for successful peer-education implementation in correctional settings. With regard to HIV/AIDS peer-education program, they conclude that peer education may be an important tool for prison prevention programs, but that rigorously designed and evaluated studies are needed to support preliminary studies.
50. Helms JL, Hirbour CA. HIV and juvenile delinquency. Am J Forensic Psychol 2004; 22:57-71. Reviewed the research on adolescents' attitudes and beliefs regarding HIV and its prevention, discussed current prevention programs for incarcerated and at-risk youth, and presented implications for professionals working in the field of juvenile forensic psychology.
51. Poehlmann J, White T, Bjerke K. Integrating HIV risk reduction into family programs for women offenders: a family relationship perspective. Family Relations 2004; 53:26-37. This article discusses the importance of integrating risk reduction into family programs for incarcerated women from a family-relationship perspective.
52. Boutwell A, Rich JD. HIV infection behind bars. Clin Infect Dis 2004; 38:1761-1763. Highlighted the number of HIV-positive individuals who pass through a US correctional system each year and advocated for routine HIV testing for incarcerated people.
53. Pontali E. Antiretroviral treatment in correctional facilities. HIV Clin Trials 2005; 6:25-37. Reviewed literature to identify and describe the relevant issues and difficulties associated with the provision of antiretroviral therapy in correctional facilities.
54. Watson R, Stimpson A, Hostick T. Prison health care: a review of the literature. Int J Nurs Stud 2004; 41:119-128. Reviewed over a decade of literature (1991-2002) to identify the main health issues impacting prison health care, and to make recommendations to improve health care for people during and after their incarceration.